SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-23-000375 from BIOLARGO, INC. (BLGO)

BIOLARGO, INC.
Date: Jan. 4, 2023 · CIK: 0000880242 · Accession: 0001437749-23-000375

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-268973

Date
January 4, 2023
Author
President
Form
CORRESP
Company
BIOLARGO, INC.

Letter

blgo20230104_corresp.htm

BioLargo, Inc.

14921 Chestnut St.

Westminster, CA 92683

Telephone: 888.400.2863

Facsimile: 949.625.9819

January 4, 2023

U.S. Securities & Exchange Commission

Division of Corporation Finance

100 F. Street NE

Washington, D.C. 20549

Re:

BioLargo, Inc.

Registration Statement on Form S-1

Filed December 23, 2022

File No. 333-268973

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLargo, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1, file number 333-268973 (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on January 6, 2023, or as soon as practicable thereafter.

The Registrant hereby acknowledges that:

(i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(iii) the Registrant may not assert comments of the Commission or the staff and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent via facsimile to 949-234-6265.

Very truly yours,
/s/Dennis P. Calvert

Show Raw Text
CORRESP
1
filename1.htm

	blgo20230104_corresp.htm

			BioLargo, Inc.

			14921 Chestnut St.

			Westminster, CA 92683

			Telephone: 888.400.2863

			Facsimile: 949.625.9819

January 4, 2023

U.S. Securities & Exchange Commission

Division of Corporation Finance

100 F. Street NE

Washington, D.C. 20549

			Re:

			BioLargo, Inc.

			Registration Statement on Form S-1

			Filed December 23, 2022

			File No. 333-268973

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLargo, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1, file number 333-268973 (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on January 6, 2023, or as soon as practicable thereafter.

The Registrant hereby acknowledges that:

(i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(iii) the Registrant may not assert comments of the Commission or the staff and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent via facsimile to 949-234-6265.

Very truly yours,

/s/Dennis P. Calvert

Dennis P. Calvert

President

BioLargo, Inc.

			cc:

			Gilbert Bradshaw, Esq.

			gbradshaw@wbc-law.com